KIMS Q1 FY26 consolidated profit slips to Rs. 78.6 Cr
KIMS has reported total income of Rs. 878.7 crores during the period ended June 30, 2025
KIMS has reported total income of Rs. 878.7 crores during the period ended June 30, 2025
Aurobindo Pharma’s US formulations revenue slipped 1.9% on a year-on-year basis to Rs. 3,488 crore
During this quarter, the company achieved a key milestone of reaching 1,000 DCGI approvals
Cupid reported total income of Rs. 64.75 crore in Q1 FY26 as compared to Rs. 44.03 crore in Q1 Fy25
With this addition, the company’s total Installed MCC Capacity will rise to 30,000 MTPA
Hikal has reported total income of Rs. 381.4 crores during the period ended June 30, 2025
The Q-Switched Nd:YAG system is suitable for all skin types and offers versatility in treating dermal and epidermal pigmentation
IOLCP has reported total income of Rs. 559.06 crores during the period ended June 30, 2025
Subscribe To Our Newsletter & Stay Updated